| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Vicarious Surgical Inc.
13D/A
RBOT · 92561V208
|
3.4% |
4/6/2026
Event 4/2/2026
|
||||
| Innovation Endeavors III LP | 3.4% | |||||
| Dror Berman | 3.4% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Eikon Therapeutics, Inc.
13G
EIKN · 282564103
|
5.0% |
5/15/2026
Event 3/31/2026
|
||||
| Innovation Endeavors III LP | 5.0% | |||||
| Innovation Endeavors III GP, LLC | 5.0% | |||||
| Innovation Endeavors IV LP | 0.9% | |||||
| Innovation Endeavors IV GP, LLC | 0.9% | |||||
| Innovation Endeavors ET SPV LP | 0.3% | |||||
| Innovation Endeavors ET SPV GP LLC | 0.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.